Could AstraZeneca's Coronavirus Vaccine Beat Pfizer and Moderna?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 25, 2020 at 10:32 AM.

  1. #1 cafead, Nov 25, 2020 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via If you had the option to get one of two effective coronavirus vaccines, one that costs $10 or one that costs $20, which one would you choose? Now that AstraZeneca (NASDAQ:AZN) is reporting that its candidate AZD1222 may be 90% effective at preventing coronavirus infections, people all over the world could soon face that choice. If approved vaccines are of equal quality, then choosing the cheaper option is easy. However, based on recent interim trial data, the decision could be more complicated once we consider safety and efficacy data.

    article source
     
    Quote

Reply to Thread